T. Rowe Price Associates’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-129,483
| Closed | -$1.15M | – | 2628 |
|
|
2017
Q3 | $1.15M | Buy |
129,483
+850
| +0.7% | +$7.55K | ﹤0.01% | 1739 |
|
|
2017
Q2 | $1.63M | Buy |
128,633
+31,513
| +32% | +$399K | ﹤0.01% | 1612 |
|
|
2017
Q1 | $1.02M | Buy |
97,120
+4,260
| +5% | +$44.8K | ﹤0.01% | 1786 |
|
|
2016
Q4 | $854K | Sell |
92,860
-19,000
| -17% | -$175K | ﹤0.01% | 1839 |
|
|
2016
Q3 | $1.32M | Sell |
111,860
-2,800
| -2% | -$33K | ﹤0.01% | 1647 |
|
|
2016
Q2 | $1.48M | Sell |
114,660
-25,000
| -18% | -$324K | ﹤0.01% | 1594 |
|
|
2016
Q1 | $2.23M | Sell |
139,660
-9,400
| -6% | -$150K | ﹤0.01% | 1500 |
|
|
2015
Q4 | $4.27M | Sell |
149,060
-5,340
| -3% | -$153K | ﹤0.01% | 1439 |
|
|
2015
Q3 | $4.39M | Buy |
154,400
+11,200
| +8% | +$319K | ﹤0.01% | 1451 |
|
|
2015
Q2 | $5.14M | Buy |
143,200
+49,000
| +52% | +$1.76M | ﹤0.01% | 1475 |
|
|
2015
Q1 | $2.74M | Buy |
+94,200
| New | +$2.74M | ﹤0.01% | 1540 |
|